Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9077 |
High Similarity |
NPD3027 |
Phase 3 |
0.8712 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8593 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8593 |
High Similarity |
NPD1613 |
Approved |
0.8358 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8195 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8195 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8189 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8175 |
Intermediate Similarity |
NPD228 |
Approved |
0.8162 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.812 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8045 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8043 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7874 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7874 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7806 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7801 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7724 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD37 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7662 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7632 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7564 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7564 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7535 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7467 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.746 |
Intermediate Similarity |
NPD940 |
Approved |
0.746 |
Intermediate Similarity |
NPD846 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7383 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7372 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7365 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7365 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7259 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7259 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7259 |
Intermediate Similarity |
NPD709 |
Approved |
0.7256 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7234 |
Intermediate Similarity |
NPD8651 |
Approved |
0.723 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7208 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD943 |
Approved |
0.719 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7174 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7171 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7171 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD2563 |
Approved |
0.717 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7165 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7164 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7163 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7113 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7107 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7103 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3144 |
Approved |
0.705 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7045 |
Intermediate Similarity |
NPD290 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7032 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7027 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7027 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7014 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5494 |
Approved |
0.6993 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6984 |
Remote Similarity |
NPD9296 |
Approved |
0.6984 |
Remote Similarity |
NPD2934 |
Approved |
0.6984 |
Remote Similarity |
NPD2933 |
Approved |
0.6982 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6982 |
Remote Similarity |
NPD7240 |
Approved |
0.6975 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6974 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD2808 |
Discontinued |
0.6974 |
Remote Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6799 |
Approved |
0.6966 |
Remote Similarity |
NPD9494 |
Approved |
0.6962 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6946 |
Remote Similarity |
NPD8252 |
Approved |
0.6946 |
Remote Similarity |
NPD8251 |
Approved |
0.6946 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6944 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6941 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD5451 |
Approved |
0.6939 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6895 |
Approved |
0.6933 |
Remote Similarity |
NPD4536 |
Approved |
0.6933 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4538 |
Approved |
0.6933 |
Remote Similarity |
NPD6896 |
Approved |
0.6929 |
Remote Similarity |
NPD3444 |
Approved |
0.6929
|
Remote Similarity |
NPD3443 |
Approved |